Skip to main content
OpenTrials

Clinical trial condition

Blood Protein Disorders

Explore clinical trials studying Blood Protein Disorders. Study availability and eligibility vary by location and protocol.

3,050 public trials 570 recruiting studies
Refine in advanced search Browse all conditions

Blood Protein Disorders trial results

Completed

A Comparative Clinical Study to Determine the Optimal Initial Therapy for Multiple Myeloma

NCT06151717

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic in Florida Jacksonville, Florida, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Mayo Clinic Health System-Franciscan Healthcare La Crosse, Wisconsin, United States
View Trial Details
Completed

Doxil/Caelyx BE Study

NCT05567601

Conditions
AIDS-Related Kaposi Sarcoma, AIDS-related Kaposi sarcoma, Adnexal Diseases, +34 more
Locations
  • HCG City Cancer Centre Vijayawada, Andhra Pradesh, India
  • Omega Hospital Visakhapatnam, Andhra Pradesh, India
  • Sanjeevani CBCC USA Cancer Hospital Raipur, Chhattisgarh, India
  • Unique Hospital Multispeciality & Research Institute Surat, Gujarat, India
View all 14 locations
View Trial Details
Completed

A Study of Ibrutinib (PCI-32765) in Chinese Participants With Relapse or Refractory Waldenstrom's Macroglobulinemia (WM)

NCT04042376

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • The First Hospital of Jilin University Changchun, China
  • First affiliated Hospital of Zhejiang University Hangzhou, China
  • Institute of Hematology and Blood Diseases Hospital Tianjin, China
  • Wuhan Union Hospital Wuhan, China
View Trial Details
Completed

Short Course Daratumumab in Patients With Multiple Myeloma

NCT03490344

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Memoral Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memoral Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States
View Trial Details
Completed

A Study of Ibrutinib in Combination With Rituximab, in Japanese Participants With Waldenstrom's Macroglobulinemia (WM)

NCT04062448

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Kameda Medical Center Chiba, Japan
  • National Cancer Center Hospital Chūōku, Japan
  • National Hospital Organization Kumamoto Medical Center Kumamoto, Japan
  • Matsuyama Red Cross Hospital Matsuyama, Japan
View Trial Details
Completed

Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial

NCT03941860

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • CHI Saint Vincent Cancer Center Hot Springs Hot Springs, Arkansas, United States
  • Mission Hope Medical Oncology - Arroyo Grande Arroyo Grande, California, United States
  • Pacific Central Coast Health Center-San Luis Obispo San Luis Obispo, California, United States
View all 222 locations
View Trial Details

Related conditions